News | November 02, 2006

New York Presbyterian Rescues Hearts with New Devices

NewYork-Presbyterian Hospital now offers a new alternative therapy for heart failure patients at risk for sudden cardiac arrest. Concerto and Virtuoso implantable defibrillators-pacemakers from Medtronic will help keep the beat for patients whose heart electrical impulses for controlling chamber contractions are impaired.

Concerto and Virtuoso have the ability to send data wirelessly to the physician's computer, allowing the physician to monitor our patients remotely, utilize wireless communication using a dedicated radio-frequency called MICS that is safe from cell-phone interference, and offer the ability to detect fluid buildup in the patient's lungs and chest—often the first sign of worsening heart failure.

The devices, each the size of a stopwatch, detect any abnormal heart rhythm such as ventricular tachycardia and automatically provide a shock to correct the problem. Additionally, the Concerto synchronizes the patient's heartbeat through a painless electric impulse to help the heart pump blood throughout the body more efficiently. The Virtuoso also provides limited pacing. Both devices are programmed to meet the individual needs of each patient.

Related Content

Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 29, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Overlay Init